BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Bao ZH, Hu C, Zhang YQ, Yu PC, Wang Y, Xu ZY, Fu HY, Cheng XD. Safety and efficacy of a programmed cell death 1 inhibitor combined with oxaliplatin plus S-1 in patients with Borrmann large type III and IV gastric cancers. World J Gastrointest Oncol 2024; 16(4): 1281-1295 [PMID: PMC11037035 DOI: 10.4251/wjgo.v16.i4.1281]
URL: https://www.wjgnet.com/1007-9327/full/v16/i4/1281.htm
Number Citing Articles
1
Zhiyuan Yu, Chen Liang, Qixuan Xu, Zhen Yuan, Miao Chen, Rui Li, Sixin Zhou, Peiyu Li, Bo Wei, Xudong Zhao. The safety and efficacy of neoadjuvant PD-1 inhibitor plus chemotherapy for patients with locally advanced gastric cancer: a systematic review and meta-analysisInternational Journal of Surgery 2025; 111(1): 1415 doi: 10.1097/JS9.0000000000002056